{
    "nctId": "NCT02954471",
    "briefTitle": "Study of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Participants With Early/Metastatic Breast Cancer in Saudi Arabia",
    "officialTitle": "A Retrospective, Observational Molecular Epidemiology Study of HER2 Expression in Patients With Early / Metastatic Breast Cancer in Saudi Arabia",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 351,
    "primaryOutcomeMeasure": "Percentage of Participants With Positive HER2 Test Result",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Initially diagnosed with breast cancer\n* Has a proven result of HER2 testing by immunohistochemistry (IHC), fluorescent in situ hybridization (FISH) or any other in situ hybridization (ISH) method\n* Alive or not alive\n\nExclusion Criteria:\n\n- Inconclusive, equivocal or unavailable result of HER2/neu overexpression by IHC and FISH",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}